|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0149566,
umls-concept:C0220901,
umls-concept:C0237881,
umls-concept:C0311392,
umls-concept:C0332293,
umls-concept:C0348016,
umls-concept:C0449259,
umls-concept:C0520997,
umls-concept:C0750502,
umls-concept:C0948008
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-2-20
|
|
pubmed:abstractText |
Hyperdense middle cerebral artery sign (HMCAS) on CT is a well known indication of thromboembolic arterial occlusion. Its disappearance after thrombolytic therapy is poorly described. Taking the rate of HMCAS disappearance as a surrogate for MCA recanalisation, its prognostic value after intravenous thrombolysis was examined.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1468-330X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
80
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
273-8
|
|
pubmed:meshHeading |
pubmed-meshheading:18931005-Aged,
pubmed-meshheading:18931005-Cohort Studies,
pubmed-meshheading:18931005-Female,
pubmed-meshheading:18931005-Fibrinolytic Agents,
pubmed-meshheading:18931005-Follow-Up Studies,
pubmed-meshheading:18931005-Humans,
pubmed-meshheading:18931005-Infarction, Middle Cerebral Artery,
pubmed-meshheading:18931005-Infusions, Intravenous,
pubmed-meshheading:18931005-Male,
pubmed-meshheading:18931005-Middle Aged,
pubmed-meshheading:18931005-Prognosis,
pubmed-meshheading:18931005-Registries,
pubmed-meshheading:18931005-Thrombolytic Therapy,
pubmed-meshheading:18931005-Tissue Plasminogen Activator,
pubmed-meshheading:18931005-Tomography, X-Ray Computed
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance.
|
|
pubmed:affiliation |
Department of Neurology, Karolinska University Hospital- Solna, SE-171 76 Stockholm, Sweden. tatiana.kharitonova@ki.se
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
